Stage 1 mesothelioma is localized. The cancer is confined to one side of the chest lining or one area of the abdomen and has ...
A 91-year-old man was admitted to the hospital with weight loss, dyspnea, and eosinophilia. An anteroposterior chest radiograph obtained 2 months earlier showed bibasilar patchy opacities. A ...
Point-of-Care Ultrasound Devices Market OverviewThe point-of-care ultrasound (POCUS) devices market is witnessing steady expansion and is expected to grow at a compound annual growth rate of ...
Point-of-care ultrasound (POCUS) is transforming pediatric clinical care by enabling rapid, non-invasive assessment of respiratory and gastrointestinal ...
Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT ...
Johnson & Johnson today announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in combination ...
Ten percent complete response and rapid, durable antitumor activity reported with RYBREVANT FASPRO; results surpass current standards of care RARITAN, N.J., Feb. 19 ...
Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as a ...
Clinicians frequently rely on expert opinions, which are sometimes later disproven by randomised controlled trials (RCTs).
This led to an extensive review of the literature, which revealed that other types of amphibole asbestos also cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results